These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24655349)

  • 1. Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia.
    Mulu A; Lange T; Liebert UG; Maier M
    BMC Infect Dis; 2014 Mar; 14():158. PubMed ID: 24655349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia.
    Kiros M; Alemayehu DH; Geberekidan E; Mihret A; Maier M; Abegaz WE; Mulu A
    Retrovirology; 2020 Sep; 17(1):33. PubMed ID: 32993693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
    Mulu A; Maier M; Liebert UG
    PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya.
    Kiptoo M; Brooks J; Lihana RW; Sandstrom P; Ng'ang'a Z; Kinyua J; Lagat N; Okoth F; Songok EM
    BMC Infect Dis; 2013 Nov; 13():517. PubMed ID: 24180455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance pattern among ART-naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    Rahman S; Sarker MS; Aralaguppe SG; Sarwar G; Khan SI; Rahman M
    J Med Virol; 2022 Feb; 94(2):787-790. PubMed ID: 34636431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.
    Soares EA; Makamche MF; Siqueira JD; Lumngwena E; Mbuagbaw J; Kaptue L; Asonganyi T; Seuánez HN; Soares MA; Alemnji G
    J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
    Xu S; Zhong P; Li J; Song A; Li H; Nie J; Li X; Wang Y
    Mol Diagn Ther; 2011 Feb; 15(1):41-52. PubMed ID: 21469769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiology of HIV-1 Subtypes and Primary Antiretroviral Resistance Profiles in Northern Cyprus: First Data Series.
    Guler E; Arikan A; Sultanoglu N; Suer K; Sanlidag T; Sayan M
    AIDS Res Hum Retroviruses; 2024 Jun; 40(6):393-400. PubMed ID: 38366753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
    Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
    PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients.
    Elmi Abar A; Jlizi A; Darar HY; Kacem MA; Slim A
    Diagn Pathol; 2012 Oct; 7():138. PubMed ID: 23044036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited increase in primary HIV-1C drug resistance mutations in treatment naïve individuals in Ethiopia.
    Huruy K; Maier M; Mulu A; Liebert UG
    J Med Virol; 2015 Jun; 87(6):978-84. PubMed ID: 25649964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
    Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
    PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.